Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dina Lev

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Plos One|December 4, 2009
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytomaJeffrey K Mito, Richard F Riedel, Leslie Dodd, et al.
The Journal of Pathology|February 2, 2012
ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumourBadreddin Edris, Iñigo Espinosa, Thomas Mühlenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2015
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J Bill, Jeannine Garnett, Isabelle Meaux, et al.
Annals of Surgical Oncology|December 11, 2012
Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancerKeila E Torres, Vinod Ravi, Katherine Kin, et al.
Annals of Surgical Oncology|March 7, 2015
Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic LesionsSean P Dineen, Christina L Roland, Rachel Feig, et al.
Annals of Surgical Oncology|January 22, 2013
Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experienceKristelle Lusby, Kari Brewer Savannah, Elizabeth G Demicco, et al.
The American Journal of Pathology|March 15, 2013
R132C IDH1 mutations are found in spindle cell hemangiomas and not in other vascular tumors or malformationsKyle C Kurek, Twinkal C Pansuriya, Maayke A J H van Ruler, et al.
Histopathology|June 4, 2014
Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic valueElizabeth G Demicco, Genevieve M Boland, Kari J Brewer Savannah, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 9, 2016
Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocationMarieke A de Graaff, Jamie S E Yu, Hannah C Beird, et al.
Cancer Biology & Therapy|December 10, 2015
Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumorChristine M Kivlin, Kelsey L Watson, Ghadah A Al Sannaa, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Plos One|December 4, 2009
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytomaJeffrey K Mito, Richard F Riedel, Leslie Dodd, et al.
The Journal of Pathology|February 2, 2012
ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumourBadreddin Edris, Iñigo Espinosa, Thomas Mühlenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2015
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J Bill, Jeannine Garnett, Isabelle Meaux, et al.
Annals of Surgical Oncology|December 11, 2012
Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancerKeila E Torres, Vinod Ravi, Katherine Kin, et al.
Annals of Surgical Oncology|March 7, 2015
Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic LesionsSean P Dineen, Christina L Roland, Rachel Feig, et al.
Annals of Surgical Oncology|January 22, 2013
Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experienceKristelle Lusby, Kari Brewer Savannah, Elizabeth G Demicco, et al.
The American Journal of Pathology|March 15, 2013
R132C IDH1 mutations are found in spindle cell hemangiomas and not in other vascular tumors or malformationsKyle C Kurek, Twinkal C Pansuriya, Maayke A J H van Ruler, et al.
Histopathology|June 4, 2014
Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic valueElizabeth G Demicco, Genevieve M Boland, Kari J Brewer Savannah, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 9, 2016
Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocationMarieke A de Graaff, Jamie S E Yu, Hannah C Beird, et al.
Cancer Biology & Therapy|December 10, 2015
Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumorChristine M Kivlin, Kelsey L Watson, Ghadah A Al Sannaa, et al.
Pageof 11